Sorrento Therapeutics Inc (SRNE)

[dia76ca]

The next two weeks should be fun for longs. I would hate to be short when the market opens Tuesday. 3 big news items coming up. Double digits here we come!
1. ACEA aquisition. Sorrento already has the rights for Abivirtinib outside of China. But the China rights to Abivertinib and worldwide rights to a phase 2 ready lupus drug would be attractive.

2. Interim results of phase 2 trials of Abivirtinib in the US and Brazil in the anti cytokine storm indication. Abivertinib already has some very worthwhile results in Phase 3 against NSCLC and phase 2 against B cell lymphomas. Will it also be useful against cytokine storm caused by Covid, pneumonia , burns etc? Will it receive an EUA?

3. EUA for Covi-Stix in US and Mexico. Rapid, low cost, 98/99% accurate, shallow nasal swab test could fill multi-billion worldwide medical need.

Combined with the growing value of the Celularity and ImmunoBio investments and very likely large settlement of PSS lawsuit...Sorrento's great portfolio in Covid, cancer and non-opioid pain will all be nicely financed with several blockbusters hitting the market this year!